Page last updated: 2024-10-26

enoxacin and Cognitive Dysfunction

enoxacin has been researched along with Cognitive Dysfunction in 1 studies

Enoxacin: A broad-spectrum 6-fluoronaphthyridinone antibacterial agent that is structurally related to NALIDIXIC ACID.
enoxacin : A 1,8-naphthyridine derivative that is 1,4-dihydro-1,8-naphthyridine with an ethyl group at the 1 position, a carboxy group at the 3-position, an oxo sustituent at the 4-position, a fluoro substituent at the 5-position and a piperazin-1-yl group at the 7 position. An antibacterial, it is used in the treatment of urinary-tract infections and gonorrhoea.

Cognitive Dysfunction: Diminished or impaired mental and/or intellectual function.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Xu, YX1
Wang, H1
Li, XK1
Dong, SN1
Liu, WW1
Gong, Q1
Wang, TD1
Tang, Y1
Zhu, J1
Li, J1
Zhang, HY1
Mao, F1

Other Studies

1 other study available for enoxacin and Cognitive Dysfunction

ArticleYear
Discovery of novel propargylamine-modified 4-aminoalkyl imidazole substituted pyrimidinylthiourea derivatives as multifunctional agents for the treatment of Alzheimer's disease.
    European journal of medicinal chemistry, 2018, Jan-01, Volume: 143

    Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Butyrylcholinesterase; Cholinesterase Inhibitors;

2018